Long Term Use of Inhaled Anticholinergic Agents in Chronic Obstructive Pulmonary Disease Patients Does Not Increase the Risk of Cardiovascular Events: A Meta-analysis of Randomized Controlled Trials

被引：0
|
作者：
Katragadda, Srikanth
Molnar, Janos
Arora, Rohit R.
机构：
[1] Mercy St Vincent Med Cntr, Toledo, OH USA
[2] Finch Univ Hlth Sci Chicago Med Sch, N Chicago, IL 60064 USA
来源：
CIRCULATION | 2010年 / 122卷 / 21期
关键词：
Cardiovascular disease; Pulmonary;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A13125
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The Use of Airway Clearance Devices in the Management of Chronic Obstructive Pulmonary Disease A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Daynes, Enya
    Jones, Arwel W.
    Greening, Neil J.
    Singh, Sally J.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (02) : 308 - 320
  • [42] Inhaled therapies and cardiovascular risk in patients with chronic obstructive pulmonary disease
    Rogliani, Paola
    Calzetta, Luigino
    Matera, Maria Gabriella
    di Daniele, Nicola
    Girolami, Andrea
    Cazzola, Mario
    Ora, Josuel
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (06) : 737 - 750
  • [43] Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis
    Chen, Wenjia
    Thomas, Jamie
    Sadatsafavi, Mohsen
    FitzGerald, J. Mark
    LANCET RESPIRATORY MEDICINE, 2015, 3 (08): : 631 - 639
  • [44] Association between inhaled corticosteroid use and risk of hyperglycemia in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis
    Kholis, Fathur Nur
    Pratama, Kevin Gracia
    Hadiyanto, Jessica Novia
    TZU CHI MEDICAL JOURNAL, 2023, 35 (04): : 355 - 361
  • [45] Apolipoprotein B and risk of cardiovascular disease: A meta-analysis of randomized controlled trials
    Galimberti, Federica
    Catapano, Alberico L.
    Katzmann, Julius L.
    Cupido, Arjen J.
    Ference, Brian A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 53 - 53
  • [46] Biologic Therapies for Chronic Obstructive Pulmonary Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
    Pitre, Tyler
    Lupas, Daniel
    Mah, Jasmine
    Stanbrook, Matthew
    Blazer, Alina
    Zeraatkar, Dena
    Ho, Terence
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2025, 22 (01)
  • [47] A mixed treatment comparison meta-analysis of randomized controlled trials of pharmacologic treatments for chronic obstructive pulmonary disease
    Baker, W. L.
    Baker, E. L.
    Coleman, C., I
    VALUE IN HEALTH, 2008, 11 (03) : A269 - A269
  • [48] Effectiveness of Proton-Pump Inhibitors in Chronic Obstructive Pulmonary Disease: A Meta-Analysis of Randomized Controlled Trials
    Yu, Fei
    Huang, Qihui
    Ye, Yousheng
    Zhang, Lin
    FRONTIERS IN MEDICINE, 2022, 9
  • [49] Risk of Major Adverse Cardiovascular Events With Inhaled Anticholinergics in Patients With Chronic Obstructive Pulmonary Disease In Reply
    Singh, Sonal
    Loke, Yoon K.
    Furberg, Curt D.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (12): : 1225 - 1226
  • [50] Inhaled corticosteroids and risk of influenza in patients with asthma: a meta-analysis of randomized controlled trials
    Chen, Hong
    Xu, Zhibo
    Yang, Jing
    Huang, Lan
    Wang, Ke
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 33 (07) : 1771 - 1782
12345